ID-1567

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameID-1567
Drug Alias Nameanti-amyloid program (Bellus)ID-1567
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein aggregation inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnodia Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInnodia IncBellus Health Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A